Sandra Rojas-Caro - 24 Jan 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Dietrich Stephan, as attorney-in-fact for Sandra Rojas-Caro
Issuer symbol
N/A
Transactions as of
24 Jan 2022
Net transactions value
$0
Form type
4
Filing time
25 Jan 2022, 13:00:28 UTC
Previous filing
25 May 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Employee stock option (right to buy) Award $0 +44,592 $0.000000 44,592 24 Jan 2022 Common stock 44,592 $1.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the total shares shall vest on the first anniversary of January 24, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date.

Remarks:

The power of attorney under which this form was signed is on file with the U.S. Securities and Exchange Commission.